SecSonar.com

Adlai Nortye Ltd. (ANL)

Adlai Nortye Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Adlai Nortye Ltd. (ANL) is a Biotechnology company based in KY with a market capitalization of $652.4M. Free cash flow was negative at -$33.7M. This page tracks ANL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

KY · 123 employees · IPO Sep 29, 2023

Valuation

Valuation & price

$12.29 · as of May 26, 2026 · -26.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$16.13$8.50$0.88Jul 25Dec 25Jul 26Jul 7, 25$1.42Jul 9, 25$1.57Jul 11, 25$1.61Jul 15, 25$1.57Jul 17, 25$1.50Jul 21, 25$1.52Jul 23, 25$1.47Jul 25, 25$1.44Jul 29, 25$1.43Jul 31, 25$1.43Aug 4, 25$1.50Aug 6, 25$1.55Aug 11, 25$1.61Aug 13, 25$1.63Aug 15, 25$1.69Aug 19, 25$1.70Aug 21, 25$1.69Aug 25, 25$1.64Aug 27, 25$1.69Aug 29, 25$1.69Sep 3, 25$1.78Sep 5, 25$1.75Sep 9, 25$1.72Sep 11, 25$1.80Sep 16, 25$1.79Sep 18, 25$1.76Sep 22, 25$1.69Sep 24, 25$1.70Sep 26, 25$1.72Sep 30, 25$1.80Oct 2, 25$1.78Oct 6, 25$1.75Oct 8, 25$1.73Oct 10, 25$1.57Oct 14, 25$1.68Oct 16, 25$1.61Oct 21, 25$1.66Oct 23, 25$1.66Oct 27, 25$1.51Oct 29, 25$1.50Oct 31, 25$1.43Nov 4, 25$1.35Nov 6, 25$1.55Nov 10, 25$1.58Nov 12, 25$1.61Nov 14, 25$1.56Nov 18, 25$1.57Nov 20, 25$1.43Nov 25, 25$1.39Nov 28, 25$1.59Dec 2, 25$1.45Dec 4, 25$1.20Dec 8, 25$0.88Dec 10, 25$1.20Dec 12, 25$1.38Dec 16, 25$1.64Dec 18, 25$1.55Dec 22, 25$1.53Dec 24, 25$1.53Dec 29, 25$1.80Jan 2, 26$1.38Jan 6, 26$1.46Jan 8, 26$1.47Jan 12, 26$1.59Jan 14, 26$1.61Jan 16, 26$1.80Jan 21, 26$1.85Jan 23, 26$2.63Jan 27, 26$3.60Jan 29, 26$6.53Feb 2, 26$9.27Feb 4, 26$10.08Feb 9, 26$10.12Feb 11, 26$9.29Feb 13, 26$9.51Feb 18, 26$9.81Feb 20, 26$9.92Feb 24, 26$10.12Feb 26, 26$9.19Mar 2, 26$8.24Mar 4, 26$8.38Mar 6, 26$8.91Mar 10, 26$8.90Mar 12, 26$8.36Mar 17, 26$8.02Mar 19, 26$7.36Mar 23, 26$6.94Mar 25, 26$7.12Mar 27, 26$6.46Mar 31, 26$6.92Apr 2, 26$8.18Apr 7, 26$9.80Apr 9, 26$12.00Apr 13, 26$12.06Apr 15, 26$13.25Apr 17, 26$16.01Apr 22, 26$16.13Apr 24, 26$14.80Apr 28, 26$12.17Apr 30, 26$14.27May 4, 26$14.97May 6, 26$14.27May 8, 26$13.28May 12, 26$13.15May 14, 26$13.86May 18, 26$11.61May 20, 26$11.36May 22, 26$11.92May 28, 26$11.30Jun 1, 26$12.03Jun 3, 26$11.26Jun 5, 26$9.95Jun 9, 26$10.84Jun 11, 26$10.20Jun 15, 26$11.33Jun 17, 26$10.26Jun 22, 26$10.40Jun 24, 26$10.99Jun 26, 26$10.00Jul 2, 26$9.34
$0.8852-week range$16.60
Loading valuation history…

Fundamentals

Key fundamentals

$652.4M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$33.7M

Free cash flow (USD)

$2.6M

Net debt

0.1%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$45.7MFY 2022$0.00FY 2023$0.00FY 2024$0.00FY 2025$5.0M
$0$5M

Free cash flow by year

2019 → 2025

FY 2019$-15.1MFY 2020$-36.2MFY 2021$-4.2MFY 2022$-44.5MFY 2023$-56.9MFY 2024$-52.0MFY 2025$-33.7M
-$15.1M-$33.7M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 20-F filed Apr 10, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $132LU YANG · Director, CEO, 10% Owner · $131.8May 21, 2026Filing
  • 6-K filingSecurities Purchase AgreementApr 16, 2026Filing
  • Annual report20-F FiledApr 10, 2026Filing
  • Annual reportAnnual Report FiledApr 1, 2026Filing

Questions

Frequently asked questions

What is Adlai Nortye Ltd.'s market cap?

Adlai Nortye Ltd. (ANL) has a market capitalization of $652.4M.

What is ANL's P/E ratio?

A meaningful P/E ratio is not available for ANL — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying ANL stock?

SEC Form 4 filings show no open-market insider buys at Adlai Nortye Ltd. in the last 90 days (1 sell).

Same arena

Related companies in Biotechnology

ESPR

Esperion Therapeutics, Inc.

$650.8M

BIOA

BioAge Labs, Inc.

$646.1M

CRMD

CorMedix Inc.

$659.8M

PRME

Prime Medicine, Inc.

$632.2M

DNA

Ginkgo Bioworks Holdings, Inc.

$628.4M

PROK

ProKidney Corp.

$621.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.